MARY KERBY: Open Payments
NPI 1811286750 · BELLA VISTA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 75 payments from 18 companies in 2025. Trend: 2023 $1,189 · 2024 $1,333 · 2025 $1,088
Food & beverage: $1,088
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $215 |
| Amgen Inc. | 13 | $164 |
| ABBVIE INC. | 15 | $162 |
| Astellas Pharma US Inc | 8 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Novo Nordisk Inc | 4 | $69 |
| Inspire Medical Systems, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
Products named: Veozah, QULIPTA, OTEZLA, NURTEC ODT, Kerendia, ELIQUIS, PREVNAR 20, Ozempic.
Industry payments across AR — which companies pay providers there.
